MALAT1 expression in tissues and secretions (e.g., cervical vaginal lavage) is highly variable and has potential use as a biomarker of cervical cancer, which could be used for clinical diagnosis and treatment (Liao et al., 2020). This evidence concerns the gene MALAT1 and cervical carcinoma.